Negative Pressure Incision Management System in Infrainguinal Vascular Surgery

NCT ID: NCT03395613

Last Updated: 2022-04-07

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 118 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-01-22
• Study Completion Date: 2023-03-31

Brief Summary

Negative pressure wound therapy (NPWT) has been used in treating postoperative SSI with encouraging results and is now an accepted element in the arsenal of tools for treating these complications. The concept of applying NPWT to closed surgical wounds as a preventive measure is relatively new but draws on the inherent properties of the method which could theoretically lead to reduced seroma formation, wound dehiscence, increased capillary circulation and consequently better wound healing and fewer SSI.

Given the incidence and the consequences of SSI in infrainguinal vascular procedures any appreciable decrease in the burden of these complications could have profound benefits for patients and healthcare facilities. As to date, there are no published data from randomized controlled trials investigating the effectiveness of this prophylactic measure.

The aim of this study is to assess the effect of NPWT applied to closed surgical wounds directly after skin closure compared to standard sterile gauze dressing in reducing the incidence and severity of postoperative SSI in infrainguinal surgical wounds in patients undergoing elective, open vascular surgery.

Detailed Description

Intervention and Surveillance:

The groin incisions in the intervention group will have NPWT dressing, applied under sterile conditions in the operating room. The NPWT will remain on the patient until postoperative day 7 or earlier if the vacuum seal is broken for any reason. If the NPWT is removed earlier than 7 days, a sterile gauze dressing will be applied to the incision.

The control group will receive a sterile gauze dressing, applied under sterile conditions in the operating room. The dressing van if needed be changed under sterile conditions at the ward on the second postoperative day. The dressing will remain on the patients until postoperative day 7. The dressing may be changed (by a research nurse or the attending surgeon), under sterile conditions if needed during the 8-day period.

After the initial 8-day period, patients in both groups will be supplied with sterile gauze dressings for an additional 6 days during which dressing changes may be carried out under sterile conditions.

All groin incisions will be examined, evaluated and categorized by a qualified research nurse or the attending surgeon, who will be blinded to the initial treatment modality, on the seventh postoperative day, 30 days postoperative and again after three months. Wound cultures will be taken (when possible) if the ASEPSIS score at any one of the three examinations is equal to, or exceeds 21 points.

Preoperative preparations will be the same for both groups. All patients will receive three doses (one pre- and two postoperative) of antibiotic prophylaxis on the day of the operation. Groin incisions will be closed with subcutaneous and intracutaneous monofilament absorbable sutures.

All patients will be asked to respond to the 36-Item Short Form Health Survey (SF-36) and the European Quality of life - Five dimensions (EQ-5D) questionnaires at the time of inclusion and at the one month follow up visit. The Wound QoL (Swedish) questionnaire will be presented to the patients at the one-week follow up.

Primary Endpoint:

• Postoperative SSI within 30 day, classified according to the scoring method ASEPSIS (Additional treatment,Serous discharge, Erythema, Purulent exudates, Separation of the deep tissues, Isolation of bacteria and in-patient Stay) and graded using the Samson classification (Grade I-V), confirmed by positive identification of the infectious agent.

Secondary Endpoints:

Postoperative SSI within 90 days, classified according to the scoring method ASEPSIS (Additional treatment,Serous discharge, Erythema, Purulent exudates, Separation of the deep tissues, Isolation of bacteria and in-patient Stay) and graded using the Samson classification (Grade I-V), confirmed by positive identification of the infectious agent.

• Antibiotic prescriptions for skin and soft tissue infections within 90 days postoperatively.
• Postoperative SSI within 90 days requiring surgical revision.
• Adverse events directly related the NPWT dressing leading discontinuation of treatment.
• Major lower limb amputation and/or mortality within 90 days postoperatively.
• Changes in reported functionality and quality of life during the 30 day postoperative period.
• Assessment of healthcare related costs within 30 days postoperatively.

Based on previous studies the incidence of postoperative groin SSI is 30-35%. Recent studies using NPWT have shown a reduction in incidence of 50% or more.

Using a sample size calculator (Sealed Envelope Ltd., Clerkenwell Workshops, London EC1R 0AT, UK) for binary outcome superiority trials with an alpha level of 0.05 for 80% power and an estimated incidence reduction from 30% to 10% using NPWT a sample size of 59 patients in each arm and a total sample size of 118 is required.

Randomization will occur once the skin incision has been closed. In cases of bilateral groin incision the right groin will be randomized and the left allocated the other arm of the trial. The surgeons, the operating room personnel and the investigators evaluating the outcome will not be blinded to the intervention.

Missing data will be treated based on the type data missing. In cases where missing data will affect the primary outcome the cases wil be deleted but accounted for in the final report.

Statistical Analysis Plan:

The data from each patient will be analysed using appropriate statistical methods for categorical and continuous and comparative analysis in respect to risk factors and outcome, both primary and secondary as previously defined. Absolute risk increase or reduction, as well as numbers needed to treat for NPWT use will be reported.

Analysis of primary outcomes will be done based on the intention to treat principle. Student's t-test and Pearson's chi-square or Fisher's exact test for continuous and categorical data, respectively. In cases where bilateral incisions are planned, the right groin will be randomized and the left will receive the alternate treatment. For subjects lost to follow up, the last recorded follow up/outcome will be recorded as their final outcome.

Analysis of secondary outcome data will be done according to normal distribution of data whrereby non-normally distributed data will be analysed using the Mann-Whitney U-test.

All tests will be 2-sided and P ≤ 0.05 will be considered statistically signinficant for all tests.

The statistical analyses will be done using SPSS version 23 (IBM, Armonk, NY, USA).

All patients will be asked to respond to the 36-Item Short Form Health Survey (SF-36) and European Quality of life - Five dimensions (EQ-5D) and Wound QoL questionnaires at the time of inclusion and at the one month follow up visit.

The data from these questionnaires will be stratified and analysed using appropriate statistical methods.

Ethical considerations:

General regulations The study will be performed in accordance with the declaration of Helsinki as revised at the 64th WMA General Assembly in Fortaleza, Brazil, October 2013. Approval of the study protocol has been obtained from the Regional Ethics Committee.

Informed consent Prior to enrolment all patients will receive written and oral information about the study. The patients will only be included after obtaining written and informed consent.

Conditions

Postoperative Surgical Site Infection

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

Standard management

Standard sterile gauze dressing on surgical groin wound.

Group Type: NO_INTERVENTION

No interventions assigned to this group

NPWT management

Negative Pressure Wound Therapy dressing on surgical groin wound.

Group Type: EXPERIMENTAL

NPWT

Intervention Type: DEVICE

Negative pressure wound thearpy on closed surgical wounds

Interventions

NPWT

Negative pressure wound thearpy on closed surgical wounds

Intervention Type: DEVICE

Other Intervention Names

Prevena

Eligibility Criteria

Inclusion Criteria

1. Patients older than 18 years.

2. The clinical criterion for study entry is elective:

a. Open infrainguinal vascular surgery for peripheral arterial disease

i. Thrombendarterectomy (TEA) ii. Bypass surgery with vein or synthetic graft

3. Patients on whom complete seal of NPWT can be maintained during the first 24 hours after operation.

-

Exclusion Criteria

1. All emergency cases.

2. Infrainguinal endovascular procedures.

3. Pre-existing groin infections.

4. Sensitivity/allergy to materials used in NPWT dressing.

5. Patients on whom an adequate and complete seal of NPWT dressing cannot be obtained.

6. Unwillingness to participate. -

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Stockholm South General Hospital

OTHER

Sponsor Role: collaborator

Karolinska University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Alireza Daryapeyma, MD PhD

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Alireza Daryapeyma, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Karolinska University Hospital

Locations

Karolinska university Hospital

Stockholm, , Sweden

Site Status: RECRUITING

Countries

Sweden

Facility Contacts

Alireza Daryapeyma, MD PhD

Role: primary

alireza.daryapeyma@sll.se

+46851700000 ext. 74104

Rebecka Hultgren, MD PhD

Role: backup

rebecka.hultgren@sll.se

+46851700000 ext. 76596

References

Vriesendorp TM, Morelis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg. 2004 Nov;28(5):520-5. doi: 10.1016/j.ejvs.2004.08.006.

Reference Type: BACKGROUND

PMID: 15465374 (View on PubMed)

Cater JE, van der Linden J. Simulation of carbon dioxide insufflation via a diffuser in an open surgical wound model. Med Eng Phys. 2015 Jan;37(1):121-5. doi: 10.1016/j.medengphy.2014.07.011. Epub 2014 Aug 5.

Reference Type: BACKGROUND

PMID: 25103346 (View on PubMed)

Turtiainen J, Saimanen EI, Makinen KT, Nykanen AI, Venermo MA, Uurto IT, Hakala T. Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg. 2012 Oct;36(10):2528-34. doi: 10.1007/s00268-012-1655-4.

Reference Type: BACKGROUND

PMID: 22618956 (View on PubMed)

Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Lowry SF, Graham AM. Infectious complications after elective vascular surgical procedures. J Vasc Surg. 2010 Jan;51(1):122-9; discussion 129-30. doi: 10.1016/j.jvs.2009.08.006. Epub 2009 Dec 2.

Reference Type: RESULT

PMID: 19954920 (View on PubMed)

Kent KC, Bartek S, Kuntz KM, Anninos E, Skillman JJ. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: incidence, risk factors, and cost. Surgery. 1996 Apr;119(4):378-83. doi: 10.1016/s0039-6060(96)80135-8.

Reference Type: RESULT

PMID: 8644000 (View on PubMed)

de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009 Jun;37(5):387-397. doi: 10.1016/j.ajic.2008.12.010. Epub 2009 Apr 23.

Reference Type: RESULT

PMID: 19398246 (View on PubMed)

Kuy S, Dua A, Desai S, Dua A, Patel B, Tondravi N, Seabrook GR, Brown KR, Lewis BD, Lee CJ, Kuy S, Subbarayan R, Rossi PJ. Surgical site infections after lower extremity revascularization procedures involving groin incisions. Ann Vasc Surg. 2014 Jan;28(1):53-8. doi: 10.1016/j.avsg.2013.08.002. Epub 2013 Nov 1.

Reference Type: RESULT

PMID: 24189008 (View on PubMed)

Krizek TJ, Robson MC. Evolution of quantitative bacteriology in wound management. Am J Surg. 1975 Nov;130(5):579-84. doi: 10.1016/0002-9610(75)90516-4. No abstract available.

Reference Type: RESULT

PMID: 1106243 (View on PubMed)

Arbeit RD, Dunn RM. Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus. J Infect Dis. 1987 Dec;156(6):947-52. doi: 10.1093/infdis/156.6.947.

Reference Type: RESULT

PMID: 3680994 (View on PubMed)

Garibaldi RA, Cushing D, Lerer T. Risk factors for postoperative infection. Am J Med. 1991 Sep 16;91(3B):158S-163S. doi: 10.1016/0002-9343(91)90362-2.

Reference Type: RESULT

PMID: 1928157 (View on PubMed)

Chang JK, Calligaro KD, Ryan S, Runyan D, Dougherty MJ, Stern JJ. Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg. 2003 Jan;17(1):91-6. doi: 10.1007/s10016-001-0337-8. Epub 2003 Jan 15.

Reference Type: RESULT

PMID: 12522701 (View on PubMed)

Anderson DJ. Surgical site infections. Infect Dis Clin North Am. 2011 Mar;25(1):135-53. doi: 10.1016/j.idc.2010.11.004.

Reference Type: RESULT

PMID: 21315998 (View on PubMed)

Lee ES, Santilli SM, Olson MM, Kuskowski MA, Lee JT. Wound infection after infrainguinal bypass operations: multivariate analysis of putative risk factors. Surg Infect (Larchmt). 2000 Winter;1(4):257-63. doi: 10.1089/109629600750067183.

Reference Type: RESULT

PMID: 12594881 (View on PubMed)

Dosluoglu HH, Loghmanee C, Lall P, Cherr GS, Harris LM, Dryjski ML. Management of early (<30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series. J Vasc Surg. 2010 May;51(5):1160-6. doi: 10.1016/j.jvs.2009.11.053. Epub 2010 Mar 31.

Reference Type: RESULT

PMID: 20356703 (View on PubMed)

Weed T, Ratliff C, Drake DB. Quantifying bacterial bioburden during negative pressure wound therapy: does the wound VAC enhance bacterial clearance? Ann Plast Surg. 2004 Mar;52(3):276-9; discussion 279-80. doi: 10.1097/01.sap.0000111861.75927.4d.

Reference Type: RESULT

PMID: 15156981 (View on PubMed)

Matatov T, Reddy KN, Doucet LD, Zhao CX, Zhang WW. Experience with a new negative pressure incision management system in prevention of groin wound infection in vascular surgery patients. J Vasc Surg. 2013 Mar;57(3):791-5. doi: 10.1016/j.jvs.2012.09.037. Epub 2013 Jan 9.

Reference Type: RESULT

PMID: 23312938 (View on PubMed)

Hyldig N, Birke-Sorensen H, Kruse M, Vinter C, Joergensen JS, Sorensen JA, Mogensen O, Lamont RF, Bille C. Meta-analysis of negative-pressure wound therapy for closed surgical incisions. Br J Surg. 2016 Apr;103(5):477-86. doi: 10.1002/bjs.10084.

Reference Type: RESULT

PMID: 26994715 (View on PubMed)

Daryapeyma A, Hammar U, Wahlgren CM. Incidence of Healthcare Associated Infections After Lower Extremity Revascularization Using Antibiotic Treatment as a Marker. Eur J Vasc Endovasc Surg. 2016 May;51(5):690-5. doi: 10.1016/j.ejvs.2015.12.016. Epub 2016 Feb 20.

Reference Type: RESULT

PMID: 26905472 (View on PubMed)

Daryapeyma A, Nilsson O, Pettersson J, Stackelberg O, Torbjornsson E, Hultgren R. Prophylactic use of incisional negative pressure wound therapy for groin incisions in vascular surgery: randomized clinical trial. BJS Open. 2025 May 7;9(3):zraf059. doi: 10.1093/bjsopen/zraf059.

Reference Type: DERIVED

PMID: 40500745 (View on PubMed)

Other Identifiers

ADaryapeyma

Identifier Type: -

Identifier Source: org_study_id